Australia in SCImago Media Rankings
Leave a comment or share on ❮ ❯ Embed
Foundation: 1926
Mission: To reduce death and disability from cardiovascular disease, diabetes and other related health disorders The Baker Heart and Diabetes Institute measures its performance, and seeks to be judged by its stakeholders and peers, on the contribution it is able to make in three areas: Scholarly achievement measured by publication number and impact, citation rates, and contribution to academic discourse which effect paradigm shifts in the discipline. Translation of research output in clinical, commercial and policy environments where new knowledge generated through the Institute's research activity have an impact on the lives of people with, or at risk, of cardiovascular disease and diabetes. Contributions to clinical service delivery and preventive health initiatives, through the successful operation of its clinics and clinical service partnerships, and the development and management of preventive health programs which contribute to the public understanding of how to prevent and manage disease.
Vision: To leverage these new capabilities, we need to draw on our expertise across a range of areas including basic science, clinical research and public health. We need to understand the mechanisms and potential drivers of disease, to test these hypotheses in patients and to understand the clinical needs. We also need to understand how the environment interacts with our genes and the role of lifestyle. That’s why the Institute is ideally placed to harness this new technology, to personalise medicine and to help people live healthier for longer.
The following data gives a quick reading on the scientific performance in the last years. The research ranking refers to the volume, impact and quality of the institution's research output. The innovation ranking is calculated on the number of patent applications of the institution and the citations that its research output receives from patents. Finally, the societal ranking is based on the number of pages of the institution's website and the number of backlinks and mentions from social networks.
The result of the evaluation of the institution can be compared to obtain a view of the country, the region to which it belongs and the institutions of the world, placing it in their respective positions.
We have divided the scientific output of the institution into 19 large areas of knowledge and the following table shows only the ranks in different territorial domains achieved by the institution in each of the areas. For an institution to have a presence in an area, it is necessary that it exceed in the last year a minimum output threshold equivalent to twice the percentage that this area represents in the world. If you need scientific indicators on these areas visit Scopus and/or SciVal.
| Area | World | Pacific Region | OECD | Australia |
|---|---|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 1003rd | 22nd | 754th | 21st |
| Chemistry | 2094th | 46th | 1398th | 42nd |
| Engineering + | ||||
| Medicine + | 1086th | 34th | 803rd | 31st |
| Pharmacology, Toxicology and Pharmaceutics | 1507th | 38th | 1044th | 34th |
These are the journals used by the institution's researchers to publish their work in the last year. The size of each circle represents the value of the SJR of the publication, and its spatial position represents its subject matter.
This visualizatión allows you to identify the knowledge areas where the institution has published, recognize the prestige of the scientific journals in which the institution knowledge has been published, and identify predominant scientific communities.
